InspireMD (NASDAQ: NSPR) — Perfil da empresa, notícias e dados financeiros
InspireMD develops innovative medical devices for vascular and coronary disease, featuring proprietary MicroNet technology.
InspireMD
InspireMD (NASDAQ:NSPR) is a medical device company focused on the development and commercialization of innovative solutions for vascular and coronary disease. The company's main project revolves around its proprietary MicroNet technology—a mesh sleeve designed to wrap around stents to prevent plaque and thrombus (blood clots) from blocking blood vessels after procedures. InspireMD aims to transform how vascular and coronary interventions are performed, striving for higher success rates and better patient outcomes. Their objectives include expanding the clinical application of their technology, gaining regulatory approvals in key markets, and establishing partnerships to enhance distribution and adoption worldwide. The company's dedication to innovation puts it at the forefront of addressing significant challenges in cardiovascular care.
Resumo
Operações
Produtos e/ou serviços de InspireMD
- CGuard™ EPS is a carotid artery disease treatment device designed to prevent stroke by utilizing MicroNet™ technology to trap potential emboli.
- MicroNet™ is a patented bio-stable mesh designed to prevent plaque and thrombus embolization from treated arterial disease sites, enhancing vascular healing.
- MGuard Prime™ EPS offers a unique combination of a coronary stent merged with MicroNet mesh for heart attack patients, aiming to protect against embolism and improve clinical outcomes.
- The MGuard™ Coronary Stent System incorporates MicroNet mesh to provide embolic protection specifically in patients with STEMI, acute myocardial infarction.
- PVGuard™ EPS is designed for peripheral vascular applications, employing MicroNet mesh to safeguard against embolic events in limbs, enhancing blood flow.
equipe executiva do InspireMD
- Marvin L. SlosmanPresident, CEO & Director
- Michael A. LawlessCFO, Secretary & Treasurer
- Vince TurturroSenior Vice President of Global Operations & Engineering
- Kathleen KennedySenior Vice President of Global Sales & Marketing
- Donna DeChantVice President of Human Resources & Organizational Development
- Amir KohenExecutive VP of Finance & Regional Manager
- Peter A. SoukasChief Medical Officer
- Sonali DewanSenior Vice President of Regulatory & Medical Affairs and Quality Assurance
- Sol J. BarerSpecial Advisor to the Board
Principais indicadores financeiros
Resultados divulgados pela InspireMD, em USD.
- Cap. de mercado
- 21,2 mi
- Receita (TTM)
- 10,8 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.6
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 9 mi | -49,1 mi | -48,8 mi | |
| 7 mi | -33,5 mi | -32 mi | |
| 6,2 mi | -21,1 mi | -19,9 mi | |
| 5,2 mi | -18,7 mi | -18,5 mi |